Global 2023 - Players, Regions, Product Types, Application & Forecast Analysis

Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period<table class='table'> <tr> <th>ATTRIBUTES</th> <th>DETAILS</th> </tr><tr> <td>STUDY PERIOD</td><td>2017-2030</td></tr><tr> <td>BASE YEAR</td><td>2023</td></tr><tr> <td>FORECAST PERIOD</td><td>2024-2030</td></tr><tr> <td>HISTORICAL PERIOD</td><td>2017-2022</td></tr><tr> <td>UNIT</td><td>VALUE (USD MILLION)</td></tr><tr> <td>KEY COMPANIES PROFILED</td><td>Acebright, Tapi Teva, Heraeus, Johson Matthey, Vinkem Labs, Chem Genix, Cipla, Qilu Pharmaceutial, Hangzhou Haoke Bio-Tech, Kunming Guiyan Pharmaceutical, Apotex Pharmachem, Dr. Reddy's Laboratories, Umicore</td></tr><tr> <td>SEGMENTS COVERED</td><td style='text-transform:capitalize;'>By Product Type - Digestive System Tumor API, Genitourinary System Tumor API, Others<br>By Application - Injection, Oral Medicine<br>By Sales Channels - Direct Channel, Distribution Channel<br>By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa</td></tr></table>

近年来，产品市场规模呈上升趋势，预计在预测期内将显著增长。<table class='table'> <tr> <th>属性</th> <th>详情</th> </tr> <tr> <td>研究周期</td> <td>2017-2030</td> </tr> <tr> <td>基准年份</td> <td>2023</td> </tr> <tr> <td>预测周期</td> <td>2024-2030</td> </tr> <tr> <td>历史周期</td> <td>2017-2022</td> </tr> <tr> <td>单位</td> <td>价值（亿美元）</td> </tr> <tr> <td>涵盖的主要公司</td> <td>Acebright, Tapi Teva, Heraeus, Johson Matthey, Vinkem Labs, Chem Genix, Cipla, Qilu Pharmaceutial, Hangzhou Haoke Bio-Tech, Kunming Guiyan Pharmaceutical, Apotex Pharmachem, Dr. Reddy's Laboratories, Umicore</td> </tr> <tr> <td>涵盖的细分市场</td> <td>按产品类型划分 - 消化系统肿瘤API，泌尿系统肿瘤API，其他<br>按应用划分 - 注射剂，口服药物<br>按销售渠道划分 - 直接渠道，分销渠道<br>按地理区域划分 - 北美，欧洲，亚太地区，南美，中东和非洲</td> </tr> </table>